Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Beyond Meat, Burcon NutraScience, Nestle - scalable growth with plant proteins

Humanity is always striving for improvement. This has not only been the case since the climate debate, but innovations in all areas of everyday life are constantly changing our lives. The changes will never again be as slow as they are at this moment. Research and development ...
Mario Hose | January 24, 2020 |

Burcon, Canopy, dynaCERT - how cannabis, proteins and hydrogen improve the world

Innovations continuously change our lives. Entrepreneurs around the globe are trying to make things happen, developing products and technologies that are designed to improve everyday life. Business areas that are scalable are particularly successful. Once a product is ready to...
Mario Hose | January 27, 2020 |

Galapagos Agrees to $3.95 Billion, 10-Year Licensing Deal Plus $1.1 Billion Investment from Gilead

Galapagos announced that Gilead Sciences has agreed to pay $3.95 billion for a 10-year partnership and licensing deal and will invest an additional $1.1 billion in newly issued shares of the company. Galapagos NV (GLPG:NASDAQ; GLPG:BSE) ADR shares opened up over 1...
Streetwise Reports | July 16, 2019 |

Burcon Nutrascience, Enthusiast Gaming, EXMceuticals - Investing in the future

Innovative technologies and social trends often determine the positive performance of an investment portfolio. The biggest challenge, however, is to recognize the development of a new need in society at the right time and to benefit from it with the right companies. But unders...
Mario Hose | April 28, 2020 |

Burcon, HelloFresh, Memphasys, TUI - winners of the Corona crisis

The past three months have changed the world. Since the outbreak of the Corona Pandemic, the travel business has come to a standstill and the supply of various food products and everyday items has been characterized by bottlenecks. The meat industry is struggling with infectio...
Mario Hose | May 22, 2020 |

How This Food Investment Company is Making the Plant-based Sector Accessible

Interest in plant-based products is hotter now more than ever, and companies in this sector are busy ramping up their efforts to meet the demand from consumers as the switch to more sustainable lifestyles continues to grow. Eat Well Investment Group Inc. ( CSE:EWG , ...
Jocelyn Aspa | February 3, 2022 |

Building a Better Covid-19 Antibody Test

ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. Testing has been an Achilles heel of the coronavirus pandemic, but ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) has partnered with Dr. Hans Frykman and the ...
Streetwise Reports | May 7, 2020 |

Protalix Shares Trade up 70% Upon Release of Phase 3 Fabry Disease Data

Shares of Protalix Biotherapeutics skyrocketed today on much higher than average volume as the firm announced positive 12-month interim data from its BRIDGE Phase 3 open label switch-over study of pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease. Earl...
Streetwise Reports | October 18, 2019 |

MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results

Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy. Clinical-...
Streetwise Reports | May 12, 2020 |

Beyond Meat Bounces Back from Sharp Decline with New 'Meatier' Burger Patty

Plant-based meat company Beyond Meat has had a volatile week, with share price dropping 25% on Tuesday. But things may be looking up again for this vegan protein producer, with shares bouncing back 12.6% on Wednesday, following the announcement of a new product. ...
Streetwise Reports | June 13, 2019 |
1 2 3 4 5 6 7 8